CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Regulation FD disclosure
- 8-K/A Event Material agreement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 100,503 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.18 ($11,800)
Page 19 of 28 · 547 filings